Antimicrobial activity of the methanolic extracts and compounds from Treculia africana and Treculia acuminata (Moraceae)  by Kuete, V. et al.
Available online at www.sciencedirect.com
ny 74 (2008) 111–115
www.elsevier.com/locate/sajbSouth African Journal of BotaAntimicrobial activity of the methanolic extracts and compounds from
Treculia africana and Treculia acuminata (Moraceae)
V. Kuete a,⁎, R. Metuno b, B. Ngameni b, A.T. Mbaveng a, F. Ngandeu c, M. Bezabih d, F.-X. Etoa a,
B.T. Ngadjui b, B.M. Abegaz d, V.P. Beng a
a Department of Biochemistry, Faculty of Science, University of Yaoundé I. PO Box 812 Yaoundé, Cameroon
b Department of Organic Chemistry, Faculty of Science, University of Yaoundé I. PO Box 812 Yaoundé, Cameroon
c Department of Organic Chemistry, Faculty of Science, University of Dschang, PO Box 67, Dschang, Cameroon
d Department of Chemistry, Faculty of Science, University of Botswana, Private Bag 00704, Gaberone, Botswana
Received 9 April 2007; received in revised form 12 September 2007; accepted 12 September 2007Abstract
The crude methanolic extracts from Treculia africana and Treculia acuminata, three compounds isolated from T. africana and identified as,
Phyllocoumarin (1), Catechin (2) and 6, 9-dihydroxy-megastigmane-3-one (3), four compounds namely 2, 3, 2,3-dihydroxypropyl-heptadecanoate
(4), and Ferulic acid (5) isolated from T. acuminata were tested for their antimicrobial activity against Gram-positive bacteria (six species), Gram-
negative bacteria (12 species) and three Candida species. The micro-dilution method for the determination of the minimal inhibition concentration
(MIC) and the Minimal microbicidal concentration (MMC) was used. The MIC values obtained with the crude extracts varied from 78 to 156 μg/
ml against 12 (57.14%) and 20 (95.24%) of the 21 tested microorganisms respectively for T. acuminata and T. africana. Apart from compound 2
that prevented the growth of all the tested microorganisms, other bioactive compounds showed selective activity. The obtained results provide
promising baseline information for the potential use of these crude extracts as well as some of the isolated compounds in the treatment of bacterial
and fungal infections.
© 2007 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Antimicrobial activity; Compounds; Moraceae; Treculia acuminata; Treculia africana1. Introduction
Traditional healing plays an integral role in black African
culture as it provides for the primary heath care needs for a large
majority (about 80%) of the population (WHO, 2002). In
Cameroon, there is a rich tradition in the use of herbal medicinal
for the treatment of various infectious diseases, inflammations,
injuries and other diseases (Adjanohoun et al., 1996). Our
herbal medicine researches include plants of the Moraceae
family. Within this family, the genus Treculia contains three
species, which are traditionally used to treat skin diseases,
dental allergy, amoebic dysentery and AIDS (Berg et al., 1985;
Bokesch et al., 2004) namely Treculia obovoidea N.E. Brown,⁎ Corresponding author. Tel.: +237 7735 59 27, +237 7533 84 55, +237 7592
71 81; fax: +237 222 60 18.
E-mail address: kuetevictor@yahoo.fr (V. Kuete).
0254-6299/$ - see front matter © 2007 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2007.09.004Treculia africana Decaisne and Treculia acuminata Baillon
(Berg et al., 1985). These species are distributed in the humid
regions of Africa, from Nigeria to Congo, including Cameroon.
To the best of our knowledge, the antimicrobial activity of these
two Treculia species as well as that of compounds such as 1, 3
and 4 has not yet been reported. The aim of this investigation
was to evaluate the antibacterial and anticandidal activities of
the crude extracts and compounds isolated from T. africana and




The twigs of T. acuminata Baillon and the leaves of
T. africana Decaisne were collected in August 2004 in Kumba,ts reserved.
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of the plants was done at the Cameroon National Herbarium,
where the voucher specimens were conserved under the
reference numbers 29053/SRF/Cam and 2921/SRF/Cam re-
spectively for T. africana and T. acuminata.
2.2. Purification and general procedures
2.2.1. T. africana
The air-dried and powdered leaves of T. africana (1 kg)
were macerated in Methanol (5 L) at room temperature for
24 h. Solvents were removed under reduced pressure to give a
dark green residue TAL (60 g). Part (55 g) of this extract was
submitted to Vacuum Liquid Chromatography (VLC) on silica
gel 60 (170 g) using petroleum ether followed by petroleum
ether 40–60/ethyl acetate gradient, and finally with EtOAc–
MeOH mixtures. A total of 40 fractions, 250 ml each, were
collected and similar fractions were combined on the TLC
basis. Fractions 1–11 (2 g) eluted with petroleum ether (40–
60), contained mainly mixtures of oils and were not
investigated further. Combined fractions 12–30 (35 g) eluted
with 20%, 30% and 60% petroleum ether–EtOAc mixtures,
respectively, were passed through a Sephadex LH-20 column
and eluted with CHCl3–MeOH (2:1) mixtures. The post-
chlorophyll fractions were also combined and subjected,
successively to silica gel CC and repeated preparative TLC
(petroleum ether–CHCl3 2:8) to afford Phyllocoumarin (1)
(20 mg; MW: 342) (Foo, 1989); Catechin (2) (25 mg; MW: 290)
(Ting Ting and Meei-Yueh, 1993; Gonzalez et al., 1994;
Siddiqui et al., 2003) and 6, 9-dihydroxy-megastigmane-3-one
(3) (15 mg; MW: 224) (Ting Ting and Meei-Yueh, 1993;
Gonzalez et al., 1994; Siddiqui et al., 2003). The following
fractions 31–36 (7 g) and 37–40 (3 g) eluted with EtOAc and
EtOAc–MeOH 15%, respectively, gave after repeated CC on
silica gel two compounds, (1) (40 mg) and (2) (30 mg).
2.2.2. T. acuminata
The air-dried and powdered twigs of T. acuminata (800 g)
were macerated in Methanol (10 L) at room temperature for
24 h. The filtrate was concentrated under vacuum to give a dark
green crude extract (TAT) (48 g).
A part of TAT (40 g) was subjected to vacuum liquid
chromatography (VLC) on silica gel (35–70 μm, 250 g) and
eluted with petroleum ether, petroleum ether/EtOAc mixtures
and EtOAc to give 46 fractions of 250 ml each. Fractions 1–25
(18 g) were diluted in acetone and after 24 h a precipitate was
formed. After filtration, Glycerol-1-hexadecanoate (4) (12 mg;
MW: 330) (Sultana et al., 1976) was obtained. The resulting
mother liquid was subjected to column chromatography over
silica gel, followed by preparative TLC (petroleum ether/
CHCl3, 2:8) to afford 8 mg of compounds 2 and a long chain
ester of Ferulic acid (5), (19 mg; MW: 558) (Wandji et al.,
1990; Achenbach et al., 1985). Fractions 26–46 (15 g), were
passed through column chromatography over silica gel and
followed by preparative TLC to give 6,9-dihydroxymegastig-
mate-3-one (3) (15 mg; MW: 224) (Ting Ting and Meei-Yueh,
1993; Gonzalez et al., 1994; Siddiqui et al., 2003).2.2.3. General procedure
Aluminium sheet pre-coated with silica gel 60 F254 nm
(Mereck) was used for thin layer chromatography and the
isolated spots were visualized using both ultra-violet light (254
and 366 nm) and 50% H2SO4 spray reagent. Petroleum ether–
CHCl3 2:8 mixtures were used for the preparative TLC. The
chemical structure of each of the isolated compound was
determined on the basis of spectral data produced by one and
two-dimensional nuclear magnetic resonance (NMR), recorded
on Brüker DRX-400 instrument. This spectrometer was
equipped with 5-mm, 1H- and 13C-NMR probes operating
at 400 and 100 MHz, with tretramethylsilane as internal
standard. Mass spectra were recorded on a API QSTAR pulsar
mass spectrometer. The structures of the compounds were
confirmed by comparing with reference data from available
literature.
2.3. Microbial strains
Twenty one species of microorganisms namely Bacillus
cereus LMP0404G, Bacillus megaterium LMP0204G, Bacillus
stearothermophilus LMP0104G, Bacillus subtilis LMP0304G,
Staphylococcus aureus LMP0206U, Streptococcus faecalis
LMP0207U (Gram positive bacteria), Escherichia coli
LMP0101U, Shigella dysenteriae LMP0208U, Proteus vul-
garis LMP0103U, Proteus mirabilis LMP0504G, Shigella
flexneri LMP0313U, Klebsiella pneumoniae LMP0210U,
Pseudomonas aeruginosa LMP0102U, Salmonella typhi
LMP0209U, Morganella morganii LMP0904G, Enterobacter
aerogens LMP 1004G, Citrobacter freundii LMP0904G, En-
terobacter cloacae LMP1104G (Gram negative bacteria),
Candida albicans LMP0204U, Candida gabrata LMP0413U
and Candida krusei LMP0311U (yeasts) were used in this
study. Three Bacillus species were provided by ‘Institut Appert
de Paris’, while B. cereus was provided by the A.F.R.C
Reading Laboratory of Great Britain. Other strains were
clinical isolates from ‘Centre Pasteur du Cameroon’, Yaoundé.
The microbial isolates were maintained on agar slant at 4 °C in
the Laboratory of Applied Microbiology and Molecular
Pharmacology (LMP) (Faculty of Science, University of
Yaoundé I) where the antimicrobial tests were performed.
The strains were subcultured on a fresh appropriate agar plate
24 h prior to any antimicrobial test.
2.4. Antimicrobial assays
2.4.1. Culture media
Nutrient Agar (NA) containing Bromocresol purple was
used for the activation of Bacillus species while NA was
used for other bacteria. Sabouraud Glucose Agar was used
for the activation of the fungi. Nutrient broth containing
0.05% phenol red and supplemented with 10% glucose
(NBGP) was used for MIC and MMC (Minimal bactericidal
concentration for bacteria and minimal candicidal concen-
tration for Candida species) determinations. The Mueller
Hinton Agar (MHA) was also used for the determination of
the MMC.
Fig. 1. Chemical structures of compounds isolated from the T. africana leaves (1, 2, 3) and T acuminata twigs (2, 3, 4, 5).
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Nystatin (Maneesh Pharmaceutic PVT. Ltd., Govandi,
Mumbai, 400 043 India) and Gentamicin [Jinling Pharmaceutic
(Group) corp., Zhejang Tieng Feng Pharmaceutic Factory,
No. 11 Chezhan Road, Huzhou city, Zhejang, China] were used
as reference antibiotics (RA) against yeasts and bacteria
respectively.
2.4.3. MIC and MMC determinations
MICs of test samples and RA were determined as follows:
the test sample was first of all dissolved in Dimethylsulfoxide
(DMSO). The solution obtained was added to NBGP to a final
concentration of 156 μg/ml for each sample and RA. This was
serially diluted two fold to obtain concentration ranges of 0.31
to 156 μg/ml. The RA solutions (in DMSO) were also prepared
following the same concentration ranges as above. 100 μl of
each concentration was added in a well (96-wells microplate)
containing 95 μl of NBGP and 5 μl of inoculum (standardised at
1.5×106 CFU/ml by adjusting the optical density to 0.1 at
600 nm SHIMADZU UV-120-01 spectrophotometer) (Ter-
eschuk et al., 1997). The final concentration of DMSO and
Tween in the well was less than 1% (preliminary analyses with
1% (v/v) DMSO/NBGP and 10% v/v Tween 20/NBGP affected
neither the growth of the test organisms nor the change of color
due to this growth). The negative control well consisted of
195 μl of NBGP and 5 μl of the standard inoculum (Zgoda and
Porter, 2001; Kuete et al., 2007). The plates were covered with a
sterile plate sealer, then agitated to mix the content of the wells
using a plate shaker and incubated at 37 °C for 24 h. The assay
was repeated twice. Microbial growth was determined byobserving the change of color in the wells (red when there is no
growth and yellow when there is growth). The lowest
concentration showing no color change was considered as the
MIC (Delaras, 1998; Kuete et al., 2006, 2007). For the
determination of MMC, a portion of liquid (5 μl) from each
well that showed no change in color was plated on MHA and
incubated at 37 °C for 24 h. The lowest concentration that
yielded no growth after this sub-culturing was taken as the
MMC (Delaras, 1998; Kuete et al., 2006, 2007).
3. Results and discussion
The structural identification of the isolated compounds 1–5
was done by comparing the spectroscopic and physical data
with that of available literature and/ or authentic markers. The
compounds isolated from T. africana (Fig. 1) were two
flavonoids identified as Phyllocoumarin (1) and Catechin (2),
and a unique ionone known as 6, 9-dihydroxy-megastigmane-3-
one (3) while compounds 2, 3 and two esters were isolated from
T. acuminata namely 2,3-dihydroxypropylhexadecanoate (4),
and aliphatic long chain ester of ferulic acid (5). Many
compounds from secondary metabolites classes such as
flavonoids and terpenoids have been reported from their
antimicrobial activity (Cowan, 1999). The inhibition potential
of compounds reported in this study is therefore in accordance
with those studies. The antibacterial and anticandidal activities
of the crude extracts and isolated compounds were evaluated
and the results are reported in Tables 1 and 2. In general, there
were differences in growth inhibition between compounds on
various microbial cultures. The crude extracts from T. africana,
Table 1
Minimum inhibition concentrations (μg/ml) of the methanolic extracts,
compounds isolated from Treculia africana leaves a, Treculia acuminata
twigs b and reference antibiotics c
Microorganisms Tested samples
TAL TAT 1 2 3 4 5 RA
Gram-negative bacteria
Citrobacter freundii 78 – 39 10 – – – 5
Enterobacter aerogens 78 78 78 20 78 78 – 10
Enterobacter cloacae 156 78 78 39 39 78 – 5
Escherichia coli 78 156 78 2 78 – – 1
Klebsiella pneumoniae 78 – – 5 – – – 2
Morganella morganii 156 – 156 10 – – – 2
Proteus mirabilis 78 156 39 5 – 78 – 2
Proteus vulgaris 78 156 78 10 – – – 1
Pseudomonas aeruginosa 156 – 39 20 – – – 2
Shigella dysenteriae 78 – 78 5 – – – 2
Shigella flexneri – – – 39 78 – – 2
Salmonella typhi 156 78 156 78 39 – – 1
Gram-positive bacteria
Streptococcus faecalis 78 156 78 20 78 78 – 2
Staphylococcus aureus 156 – – 10 – – – 5
Bacillus cereus 78 – 39 10 – – – 2
Bacillus megaterium 78 78 78 20 39 – – 1
Bacillus stearothermophilus 156 – 78 20 – – – 5
Bacillus subtilis 78 156 78 20 78 – – 2
Yeasts
Candida albicans 78 156 78 5 39 – – 2
Candida gabrata 156 156 156 20 39 – – 2
Candida krusei 78 156 78 10 78 – – 10
a Compounds isolated from the leaves of Treculia africana (TAL):
Phyllocoumarin (1) and Cathechin (2) and 6, 9-dihydroxy-megastigmane-3-
one (3).
b Compounds isolated from the twigs of Treculia acuminata (TAT):
compound 2; 3; 2, 3-dihydroxypropyl heptadecanoate (4), and Ferulic acid (5).
c RA: Reference antibiotics (Gentamicin for bacteria, nystatin for yeast); (–):
MICN156 μg/ml.
Table 2
Minimum microbicidal concentrations (μg/ml) of the methanolic extracts,
compounds isolated from Treculia africana leaves a, Treculia acuminata twigs b
and reference antibiotics c
Microorganisms Tested samples
TAL TAT 1 2 3 4 5 RA
Gram-negative bacteria
Citrobacter freundii 156 – 78 20 – – – 10
Enterobacter aerogens 156 156 156 39 156 156 – 20
Enterobacter cloacae nd nd 156 156 156 156 – 10
Escherichia coli 156 nd nd 5 156 – – 2
Klebsiella pneumoniae 156 – – 10 – – – 5
Morganella morganii nd – nd 20 – – – 5
Proteus mirabilis 156 nd 78 20 – 156 – 5
Proteus vulgaris 156 nd 156 20 – – – 2
Pseudomonas aeruginosa nd – 78 39 – – 5
Shigella dysenteriae 156 – 156 10 – – – 5
Shigella flexneri – – – 78 nd – – 5
Salmonella typhi nd 156 nd nd 156 – – 2
Gram-positive bacteria
Streptococcus faecalis 156 nd 156 39 156 nd – 5
Staphylococcus aureus nd – – 20 – – – 10
Bacillus cereus 156 – 156 39 – – – 5
Bacillus megaterium 156 156 156 39 78 – – 2
Bacillus stearothermophilus nd – 156 78 – – – 10
Bacillus subtilis 156 nd 156 39 156 – – 5
Yeasts
Candida albicans 156 nd 156 20 78 – – 5
Candida gabrata nd nd nd 39 78 – – 5
Candida krusei 156 nd nd 20 156 – – 20
a Compounds isolated from the leaves of Treculia africana (TAL):
Phyllocoumarin (1) and Cathechin (2) and 6, 9-dihydroxy-megastigmane-3-
one (3).
b Compounds isolated from the twigs of Treculia acuminata (TAT):
compound 2; 3; 2, 3-dihydroxypropyl heptadecanoate (4), and Ferulic acid (5).
c RA: Reference antibiotics (Gentamicin for bacteria, nystatin for yeast); (-):
Not tested because the MIC was not determined; (nd): not determined because
MMCN156 μg/ml.
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antibacterial and anticandidal activities at the tested MIC limit
of 156 μg/ml (Table 1). The MIC values obtained with the crude
extracts varied from 78 to 156 μg/ml on 12 (57.14%) and 20
(95.24%) of the 21 tested microorganisms respectively for TAT
and TAL. Compound 2 isolated from TAL was active on all the
tested microorganisms while compound 1 inhibited the growth
of 18 (85.71%) of them. Compound 5 was not active at the
tested MIC limit. Apart from compound 2, no other compound
isolated from the two crude extracts was able to prevent the
growth of all Gram-negative cultures. Regarding the degree of
activity of the isolated compounds, the lowest MIC value (2 μg/
ml) was observed with compound 2 on E. coli. This compound
appeared to be very active, with the MIC value of 5 μg/ml also
observed on 4 of the tested microbial cultures namely
K. pneumoniae, P. mirabilis, S. dysenteriae and C. albicans.
The results of the MMC determinations (Table 2) indicated that
the MMC values lower than 156 μg/ml were observed with
crude extracts on 25% (3/12) and 65% (13/20) of the sensitive
microbial species respectively for TAT and TAL. Within the
tested interval (0.31–156 μg/ml), the MMC values wereobtained with compounds on 0 to 100% of the tested microbial
species.
When comparing the MIC interval of the antimicrobial
activity of the tested samples to that of Gentamicin (1–10 μg/
ml) and nystatin (2–10 μg/ml) used as reference antibiotics, the
inhibition potency of tested compounds (except compound 5) as
well as that of the two crude extracts could mostly be considered
as important. The results of the MMC determinations (Table 2)
indicated that cidal effect of many of the tested sample could be
expected. However, a keen look of the results of MIC (Table 1)
and MMC (Table 2), showed that the MIC values obtained are 4
times lesser than the MMCs on corresponding (sensitive)
microorganisms, confirming the microbicidal effects of the
concerned samples (Carbonnelle et al., 1987).
The locally isolated microorganisms were mostly used in this
study, in order to close up our experiment to the local condition
of the use of T. africana and T. acuminata. To the best of our
knowledge, the antibacterial and the anticandidal activities of
the two extracts as well as that of compounds 1, 3 and 4 is being
reported for the first time. Nevertheless, this study supports the
traditional use of plants of the genus Treculia in the treatment of
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(Berg et al., 1985; Bokesch et al., 2004). The flavonoids isolated
from the crude extracts exhibited a very good antibacterial and
anticandidal activities. However, the antimicrobial activity of
Catechin against bacteria species and fungi has previously been
reported by Bruneton (1999), and this is confirmed by the
present study. The activity of flavonoids tested in this study (1
and 2) seems to be related to their degree of hydroxylation.
From the results of Table 1, it can be observed that Catechin
with 5 hydroxy (–OH) groups prevents the growth of 100% of
the tested microorganisms. However, several authors have
previously confirmed this hypothesis (Sato et al., 1996; Cowan,
1999).
The known antimicrobial mechanisms associated to each
class of chemical to which the isolated compounds belong, may
explain the antimicrobial potency of the crude extracts and
compounds from T. africana and T. acuminata. The activity of
flavonoids such as compounds 1 and 2 might be due to their
ability to complex with bacterial cell wall (Cowan, 1999) and
therefore, inhibiting the microbial growth. Finally, the antimi-
crobial activity of the two extract from Treculia species may be
due to the presence of both antifungal and antibacterial
compounds. The present study provides an important basis for
the use of extracts from these plants for the treatment of in-
fections associated to the studied microorganisms. The crude
extracts as well as the isolated compounds found active could be
useful for the development of new antimicrobial drug. However,
pharmacological and toxicity studies currently going on in our
laboratory will be necessary to confirm this hypothesis.
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